The IRC's Board
Directors of the Corporation's Board are members of the Corporation who are elected at the annual general meeting of the members. Directors have a fiduciary obligation to act in the best interests of the Corporation and they are accountable to the members.
The Board has the responsibility to elect or appoint its officers, including the Chair, any Vice-Chair or other officers, the CEO, and the Board Secretary. The CEO is a member of the Board.
The Board may appoint ex-officio (non-voting) members to attend Board meetings as observers. Generally such appointments are made to allow key stakeholders to be involved in IRC affairs, even if it is not appropriate for them to be a part of the formal governance structure of the Corporation.
The current members of the Board are:
· Martin Godbout - Genome Canada (Chair)
· Michael Rudnicki – OHRI (CEO and SD)
· Christian Desaintes – European Commission
· Jean Marc Egly – France
· Claude Benchimol – Invitrogen now Life Technologies
· Allan Bradley – Sanger
· Mona Nemer – University of Ottawa
· Edison Lui – Singapore
· Christian Burks – OGI (ex-officio)
· Elise Feingold – NIH/ENCODE (ex-officio)
